Rupa Cornell

Rupa Cornell is an accomplished legal professional with extensive experience in the pharmaceutical and biotechnology sectors, currently serving as VP, Head Counsel for the Vaccines Business Unit at Takeda, where responsibilities include providing legal guidance for global vaccine launches and partnership negotiations related to COVID-19. Rupa holds board positions at Next Generation Investment and the Massachusetts Technology Collaborative, actively contributing to organizations focused on education and economic growth. Previous roles include Deputy General Counsel at Stealth BioTherapeutics, General Counsel for the Americas at Stallergenes Greer, and Senior Director of Legal at Sage Therapeutics, among others. Rupa earned a JD, cum laude, from Cornell Law School and a BA, summa cum laude, from Vanderbilt University.